Cencora [COR] vs Henry Schein [HSIC] Detailed Stock Comparison
Cencora
NYSE
Loading...
Henry Schein
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Cencora wins in 9 metrics, Henry Schein wins in 10 metrics, with 0 ties. Henry Schein appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Cencora | Henry Schein | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 33.80 | 21.79 | Henry Schein |
| Price-to-Book Ratio | 55.93 | 2.40 | Henry Schein |
| Debt-to-Equity Ratio | 827.73 | 68.55 | Henry Schein |
| PEG Ratio | 17.87 | -1.77 | Henry Schein |
| EV/EBITDA | 14.99 | 12.42 | Henry Schein |
| Profit Margin (TTM) | 0.55% | 3.05% | Henry Schein |
| Operating Margin (TTM) | 1.34% | 5.40% | Henry Schein |
| EBITDA Margin (TTM) | 1.34% | 5.40% | Henry Schein |
| Return on Equity | 141.78% | 8.12% | Cencora |
| Return on Assets (TTM) | 2.97% | 4.54% | Henry Schein |
| Free Cash Flow (TTM) | $3.00B | $661.00M | Cencora |
| Dividend Yield | 0.54% | N/A | N/A |
| 1-Year Return | 27.55% | -3.69% | Cencora |
| Price-to-Sales Ratio (TTM) | 0.18 | 0.64 | Cencora |
| Enterprise Value | $64.62B | $12.89B | Cencora |
| EV/Revenue Ratio | 0.21 | 1.01 | Cencora |
| Gross Profit Margin (TTM) | 4.06% | 31.36% | Henry Schein |
| Revenue per Share (TTM) | $1,587 | $103 | Cencora |
| Earnings per Share (Diluted) | $8.65 | $3.11 | Cencora |
| Beta (Stock Volatility) | 0.60 | 0.82 | Cencora |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Cencora vs Henry Schein Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Cencora | -0.15% | 2.84% | 3.61% | 4.07% | 25.60% | 34.92% |
| Henry Schein | -0.63% | 0.44% | -1.25% | -5.37% | -11.69% | -0.50% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Cencora | 27.55% | 107.42% | 210.85% | 200.61% | 993.51% | 1,619.97% |
| Henry Schein | -3.69% | -7.06% | 2.66% | 24.77% | 227.30% | 329.80% |
Performance & Financial Health Analysis: Cencora vs Henry Schein
| Metric | COR | HSIC |
|---|---|---|
| Market Information | ||
| Market Cap | $56.66B | $8.22B |
| Market Cap Category | Large cap | Mid cap |
| 10 Day Avg. Volume | 1,656,160 | 2,292,793 |
| 90 Day Avg. Volume | 1,730,300 | 1,958,574 |
| Last Close | $303.23 | $68.21 |
| 52 Week Range | $218.65 - $309.35 | $60.56 - $82.49 |
| % from 52W High | -1.98% | -17.31% |
| All-Time High | $309.35 (May 05, 2025) | $92.68 (Apr 11, 2022) |
| % from All-Time High | -1.98% | -26.40% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | 0.03% |
| Quarterly Earnings Growth | 0.71% | -0.17% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.03% |
| Operating Margin (TTM) | 0.01% | 0.05% |
| Return on Equity (TTM) | 1.42% | 0.08% |
| Debt to Equity (MRQ) | 827.73 | 68.55 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $5.23 | $28.26 |
| Cash per Share (MRQ) | $10.21 | $1.20 |
| Operating Cash Flow (TTM) | $4.11B | $512.00M |
| Levered Free Cash Flow (TTM) | $3.88B | $358.25M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.54% | N/A |
| Last 12-Month Dividend | $1.61 | N/A |
Valuation & Enterprise Metrics Analysis: Cencora vs Henry Schein
| Metric | COR | HSIC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 33.80 | 21.79 |
| Forward P/E | 17.87 | 13.03 |
| PEG Ratio | 17.87 | -1.77 |
| Price to Sales (TTM) | 0.18 | 0.64 |
| Price to Book (MRQ) | 55.93 | 2.40 |
| Market Capitalization | ||
| Market Capitalization | $56.66B | $8.22B |
| Enterprise Value | $64.62B | $12.89B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.21 | 1.01 |
| Enterprise to EBITDA | 14.99 | 12.42 |
| Risk & Other Metrics | ||
| Beta | 0.60 | 0.82 |
| Book Value per Share (MRQ) | $5.23 | $28.26 |
Financial Statements Comparison: Cencora vs Henry Schein
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | COR | HSIC |
|---|---|---|
| Revenue/Sales | $81.49B | $3.17B |
| Cost of Goods Sold | $78.93B | $2.17B |
| Gross Profit | $2.56B | $1.00B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $807.49M | $200.00M |
| EBITDA | $1.06B | $278.00M |
| Pre-Tax Income | $620.45M | $145.00M |
| Income Tax | $126.73M | $35.00M |
| Net Income (Profit) | $493.72M | $113.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | COR | HSIC |
|---|---|---|
| Cash & Equivalents | $3.22B | $127.00M |
| Total Current Assets | $49.99B | $4.04B |
| Total Current Liabilities | $54.51B | $2.92B |
| Long-Term Debt | $5.94B | $2.22B |
| Total Shareholders Equity | $361.90M | $4.72B |
| Retained Earnings | $5.79B | $3.63B |
| Property, Plant & Equipment | N/A | $850.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | COR | HSIC |
|---|---|---|
| Operating Cash Flow | $-2.44B | $147.00M |
| Capital Expenditures | N/A | $-31.00M |
| Free Cash Flow | $-2.82B | $-6.00M |
| Debt Repayment | $-13.47B | $-15.00M |
| Common Stock Repurchase | $-385.47M | $-161.00M |
Short Interest & Institutional Ownership Analysis
| Metric | COR | HSIC |
|---|---|---|
| Shares Short | 6.63M | 7.78M |
| Short Ratio | 3.24 | 4.75 |
| Short % of Float | 0.06% | 0.07% |
| Average Daily Volume (10 Day) | 1,656,160 | 2,292,793 |
| Average Daily Volume (90 Day) | 1,730,300 | 1,958,574 |
| Shares Outstanding | 194.94M | 124.16M |
| Float Shares | 182.64M | 103.82M |
| % Held by Insiders | 0.06% | 0.01% |
| % Held by Institutions | 0.94% | 1.14% |
Dividend Analysis & Yield Comparison: Cencora vs Henry Schein
| Metric | COR | HSIC |
|---|---|---|
| Last 12-Month Dividend | $1.61 | N/A |
| Last 12-Month Dividend Yield | 0.54% | N/A |
| 3-Year Avg Annual Dividend | $1.84 | N/A |
| 3-Year Avg Dividend Yield | 0.26% | N/A |
| 3-Year Total Dividends | $5.52 | N/A |
| Ex-Dividend Date | Feb 14, 2025 | N/A |